1 March, 2023Chroma Medicine secures $135M in Series B financing to advance breakthrough epigenetic editing technology and expand pipeline of durable precision genomic medicines
19 January, 2023PinCell announces the development of a key transgenic mouse model and the appointment of Dr. Antonino Amato as CEO
20 December, 2022AAVantgarde Founder and Chief Scientific Officer, Professor Alberto Auricchio, is elected as Vice President of the European Society of Gene and Cell Therapy